Scientists now understand why a common childhood vaccine reduces the risk of leukemia.
Researchers previously knew that the vaccine against Haemophilus influenza type B, or HiB, reduces the risk of acute lymphoblastic leukemia, the most common form of childhood cancer. But now a new study published in Nature Immunology explains why this is the case.
Dr. Markus Müschen and his team on the study used a mouse model and found that recurring HiB infections, which can happen easily in children who have not been vaccinated, can cause certain enzymes to activate and push common precancerous blood cells into cancer. So, vaccines against HiB infections also protect children from this path to leukemia.
Müschen told the New York Times that the HiB vaccine, which is routinely given to children, has led to a 20% reduction in the risk for leukemia.
- Can Birth Control Help Solve the World's Rat Problem?
- About That Devastating Tom-Shiv Scene in Succession's Premiere
- Why Humza Yousaf's Win Is 'Historic' for Scotland
- For Both Donald Trump and Alvin Bragg, the Central Park Jogger Case Was a Turning Point
- If Donald Trump Is Indicted, Here's What Would Happen Next in the Process
- Alison Roman Won't Sugarcoat It
- Why Not All Observant Muslims Fast During Ramadan
- It's Time to Say a Loving Goodbye to John Wick
- Who Should Be on the 2023 TIME100? Vote Now
- Column: Ozempic Exposed the Cracks in the Body Positivity Movement
